Congestive Heart Failure: Mulualem W.MD Dmu, Department of Internal Medicine For Ho Students

Congestive Heart Failure
Mulualem W.MD
DMU,DEPARTMENT OF INTERNAL
MEDICINE
FOR HO STUDENTS
Congestive heart failure
 Heart failure : inability of the heart to pump
an adequate amount of blood to the body
relative to the body’s demand.
 Congestive heart failure : state in which
abnormal circulatory congestion existsas a

result of heart failure.
-Backward vs forward HF
-Left vs right HF
-Highoutput vs lowoutput HF
Sunday, December 13, 2020 3
Causes
 Impaired myocardial contractility

 Increased ventricular stiffness or impaired
myocardial relaxation
 Others:
 valve disease
 Intra cardiac shunting
 Disorders of heart rate or rhythm
 Increased peripheral blood flow or metabolic
requirements
Precipitating factors for heart failure
 The most important precipitating factors may be represented
with the mnemonic, HEART FAILES
H- Hypertension (systemic)
E- Endocarditis (infections)
A- Anemia
R- Rheumatic fever and myocarditis
T- Thyrotoxicosis and pregnancy
F- Fever (infections)
A- Arrhythmia
I- infarction (myocardial)
L- Lung infection
E- Embolism (pulmonary)
S- Stress (emotional, physical, environment, dietary, fluid excess)
Manifestations of heart failure …
 Dyspnea
 Orthopnea
 Paroxysmal Nocturnal Dyspnea
 Fatigue and weakness
 Cheyne-Stokes respiration
 Physical Findings
 ↑ JVP or positive hepato jugular reflux
 S3 gallop
 pulmonary rales
 Edema
Diagnosis of heart failure
 Hx
 P/E
 Ix
 Framingham criteria(Hx &P/E)
 Major criteria Minor criteria
 PND Exterimity edema
 Neck vein distention Night cough
 Rales Dyspnea on exertion
 Cardiomegally Hepatomegally
 Acute plumonary edema Pleural effusion
Con`t
 S3gallope VC reduced
by1/3
 Increased venous pressure Tachycardia
 Positive hepato jugullar reflex
 Dx by atleast 1Mj and 2Minor criterias

NYHA classification
Class1 : Without limitation of physical activity.
ordinary PA doesnot cause fatigue,palpitation,dyspnea
or anginal pain
Class2 : Slight limitation of PA
Comfortable at rest
Ordinary activities case fatigue,palpitation,dyspnea or
angina.
Class3 : Marked limitation of PA
Comfortable at rest
Less than ordinary activities cause Sx
Class 4:Inability to carry out ordinary activities W/O
discomfort.
Sx present at rest.
Stages of heart failure
Stage A:At risk of developing HF but with out

disease or Sx of HF
e.g pt with HTN,DM
Stage B:Structural heart disease without Sx of HF
e.g pt with previus MI or Asx LV
dysfunction
StageC:Structural heart disease ,Sxtic
e.g pt with previous MI with dyspnea & fatigue
Stage D:Pt with refractory HF requiring special intervention
e.g pt with refractory Hf requiring cardiac
transplantation
Treatment
 Prevent HF
 Prevent disease progression wtth drugs
 Sxic managment
 Therapy depending on NYHA classification
Asxit(class 1) -Rx slow disease progression(By

blockig neuro hormonal systems that
lead tocardiac remodelling)
Sxtic(class 2-4)-Alleviate fluid retention
-Lessen disability
-Decrease risk of further disability
Principles of managment
 General measures
 Identification and treatment of prcipitating
factors
 Control of congestive state
 Improve myocardial performance
 Prevention of deterioration of myocardial
function
 Treatment of underlying cause
General measures
 Rest and positioning
 Screen for and treat comorbidities
 Aviod drugs that worsen HF:NSAIDS
 Dietary salt restriction(<3g/day)
 Fluid restriction(<21days)
 Caloric supplementation:pt with advanced HF
&weight loss
Activity and life style modification
Control of congestive state.
Diuretics
relive congestion and prevent edema
Cntrl fluid retension in advanced HF
Loop diuretics
Addition of thiazide diuretics to loop diuretics
Enhancing myocardial activity
 Digoxine: ionotropic effect
 Neurohormonal modulation
 Pt with Sxtic lv systolic dysfunction esp if they
have atrial fibrillation

 Pt who have Sx&Stm of HF while recieving
standard treatment(ACEI+Bblocker)
vasodilators
 In pt with sever acute HF with systemic
vasoconstiction despite ACE therapy
 decreased peripheral resistance and after
load
improve cardiac perfomance
hydralizine
Isosorbide
dinitrate
D. Prevention of deterioration of myocardial
function and disease progression
 By inhibiting the neurohormonal measures
which cause cardiac remodelling and
progression of HF
 DRUGS THAT INTERFERE WITH EXCESS
ACTIVATION OF RAAS AND ADRENGIC NS

◦ ACEIs
Afterload reduction and neurohormonal modulation
DRUGS captopril, Enalaprin
Anti coagulant and antiplatlet
therapy
 Pts with HF have an increased risk of
thromboembolic events
 Decreased LV function promote stasis of
blood in dilated cardiac chambers with

increased risk of thrombus formation
◦ Warfarin
.
◦ Aspirin
 HF pts with MI
Mngt of acute HF
 Goals
◦ Stabilization of hemodynamic derangements that
proceed the signs
◦ Identification and Rx of factors that precipitated
decompensation
◦ Prevention of d’se progression and relapse
 Vasodilators
◦ IV vasodilators
 Nitroglycerin
 Nitrorusside............ Dilatation of arterial resistance
and venous capacitance..........
 Lowering of LV filling pressure and improve forward COP
S/E... Hypotension and hypoxia
.
 Ionotopic agents
◦ Stimulate contrality and produce vasodilation.........
Increasing COP
◦ Eg dobutamine and Milirinone
 Vasoconstrictors
Dopamine...... B- agonist, increase contractility and
selective renal vasodilator
Mechanical and surgical
interventions
 If physiologic intrevention fail to estabilize
the pt with refractory HF
General measures
 Rest
 Positioning
 Diatry salt restriction( >3g/dl)
 Fluid restriction (<2g/day)
 Avoid extrem tempratures, cessation of
smoking, limitation of alcohol intake

 PPV along with other drugs
Specific measures
1. Enhance myocardial contractility
2. Removal of excessive retained fluid and
NA+
3. Identification and Rx of precipitating factors
4. Correction of underlying cause/s
Underlying causes
1. Decrease contraction.............. VHD, CHD,
CMP
2. Increased preload.............. Systemic HTN
3. Abnormalities in preload............ Excessive/
decreased
4. decreased compliance states..........
Constictive precarditis, RCMP
References
 Harrison`s principles of internal medicine
.
you !! !!
 Thank

Congestive Heart Failure: Mulualem W.MD Dmu, Department of Internal Medicine For Ho Students

Uploaded by

Copyright:

Available Formats

Congestive Heart Failure: Mulualem W.MD Dmu, Department of Internal Medicine For Ho Students

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Congestive Heart Failure: Mulualem W.MD Dmu, Department of Internal Medicine For Ho Students

Uploaded by

Copyright:

Available Formats

Congestive Heart Failure

abnormal circulatory congestion existsas a

 Impaired myocardial contractility

 Dx by atleast 1Mj and 2Minor criterias

Stage A:At risk of developing HF but with out

Asxit(class 1) -Rx slow disease progression(By

have atrial fibrillation

ACTIVATION OF RAAS AND ADRENGIC NS

blood in dilated cardiac chambers with

smoking, limitation of alcohol intake

You might also like